Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Icon Genetics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12327
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Icon Genetics GmbH (Icon Genetics), a subsidiary of Denka Co Ltd, is a technology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and plant-based production. It commercializes proprietary transgene operating systems suites of technologies for nuclear transformation of plants, plastid transformation and pro-viral transfection of plants. The company offers production platforms and product prototypes for various pharmaceutical, animal health and chemical biotech markets. Icon Genetics is headquartered in Halle, Germany.

Icon Genetics GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Merger 11
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Acquisition 12
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH – Key Competitors 14
Icon Genetics GmbH – Key Employees 15
Icon Genetics GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH, Key Competitors 14
Icon Genetics GmbH, Key Employees 15

List of Figures
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eneva SA (ENEV3):石油・ガス:M&Aディール及び事業提携情報
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • Amazon.com Inc (AMZN):企業の財務・戦略的SWOT分析
    Amazon.com Inc (AMZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Schneider Electric SE (SU):企業の財務・戦略的SWOT分析
    Schneider Electric SE (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • John Wood Group Plc (WG.):石油・ガス:M&Aディール及び事業提携情報
    Summary John Wood Group Plc (Wood) is a provider of project, engineering and technical services. The company offers comprehensive solutions that improve the performance of customers' industrial assets across the asset life cycle. Its services span from concept to decommissioning and include asset so …
  • FUJIFILM Medical Systems USA Inc:企業の戦略的SWOT分析
    FUJIFILM Medical Systems USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Advanced Accelerator Applications SA (AAAP):企業の財務・戦略的SWOT分析
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • Brigham and Women’s Hospital:企業のM&A・事業提携・投資動向
    Brigham and Women's Hospital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brigham and Women's Hospital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • MetGen Oy:電力:M&Aディール及び事業提携情報
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company offers metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosic …
  • Exeltis Pharmaceuticals Holding SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Exeltis Pharmaceuticals Holding SL (Exeltis), a subsidiary of Insud Pharma, is a developer, producer, and marketer of medicinal products and medical devices. The company provides products in the therapeutic areas including women’s health, dermatology, respiratory, central nervous system, inf …
  • United States Endoscopy Group Inc:企業の戦略的SWOT分析
    United States Endoscopy Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Oriental Bank of Commerce:企業のM&A・事業提携・投資動向
    Oriental Bank of Commerce - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Oriental Bank of Commerce Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • AxoGen Inc (AXGN):企業の財務・戦略的SWOT分析
    Summary AxoGen Inc (AxoGen) formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company's products include AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among other …
  • TiVo Corp.:企業の戦略・SWOT・財務情報
    TiVo Corp. - Strategy, SWOT and Corporate Finance Report Summary TiVo Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sagemcom SAS:企業の戦略的SWOT分析
    Sagemcom SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • The Eat Out Group, SL:企業の戦略・SWOT・財務情報
    The Eat Out Group, SL - Strategy, SWOT and Corporate Finance Report Summary The Eat Out Group, SL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aptech Ltd. (APTECHT):企業の財務・戦略的SWOT分析
    Aptech Ltd. (APTECHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Calpine Corporation:企業の戦略・SWOT・財務情報
    Calpine Corporation - Strategy, SWOT and Corporate Finance Report Summary Calpine Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vedanta Resources Plc
    Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Vedanta Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Northern Oil & Gas Inc (NOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Northern Oil & Gas Inc (Northern) is an oil and gas company that offers acquisition, exploration and production services. The company acquires and maintains oil and natural gas properties in Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana. It offers s …
  • Medigen Biotechnology Corp (3176)-医療機器分野:企業M&A・提携分析
    Summary Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆